2020
DOI: 10.1007/s10517-020-04920-8
|View full text |Cite
|
Sign up to set email alerts
|

Osteogenic Potential of Decellularized Tooth Matrix

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…The decellularization of the PDL strips and tooth particles was carried out by sequential incubation with a 1% SDS solution (Sigma-Aldrich, St. Louis, MO, USA), a 1% Triton X-100 solution (Sigma-Aldrich, USA), and a DNase solution (20 µg/mL; Sigma-Aldrich, USA) in 4.2 mM MgCl 2 (Sigma-Aldrich, USA) [35]. Further, the samples were incubated in DMEM culture medium (Gibco, Thermo Fisher Scientific, USA) with antibiotics (300 U/mL penicillin, 300 µg/mL streptomycin, and 75 µg/mL amphotericin B) (Gibco, USA) and stored at −70 • C. All treatment steps were applied to samples at room temperature with constant gentle agitation of the samples in an orbital shaker (Corning™ LSE™, USA).…”
Section: Decellularization Of Pdl Strips and Tooth Particlesmentioning
confidence: 99%
“…The decellularization of the PDL strips and tooth particles was carried out by sequential incubation with a 1% SDS solution (Sigma-Aldrich, St. Louis, MO, USA), a 1% Triton X-100 solution (Sigma-Aldrich, USA), and a DNase solution (20 µg/mL; Sigma-Aldrich, USA) in 4.2 mM MgCl 2 (Sigma-Aldrich, USA) [35]. Further, the samples were incubated in DMEM culture medium (Gibco, Thermo Fisher Scientific, USA) with antibiotics (300 U/mL penicillin, 300 µg/mL streptomycin, and 75 µg/mL amphotericin B) (Gibco, USA) and stored at −70 • C. All treatment steps were applied to samples at room temperature with constant gentle agitation of the samples in an orbital shaker (Corning™ LSE™, USA).…”
Section: Decellularization Of Pdl Strips and Tooth Particlesmentioning
confidence: 99%
“…The bone tissue engineering strategy by decellularizing xenogeneic or allogeneic bone to construct extracellular matrix (ECM)-derived graft material has provided an alternative promising treatment. ECM provides a supportive three-dimensional microenvironment network for cell adhesion, proliferation, and differentiation. , The decellularized bone matrix (DCB) constructed by removing the cellular and immunogenic components in the ECM of bone in vitro by physical, chemical, and enzymatic methods retains the structural characteristics and represents the native bone-specific microenvironment of ECM. , The DCB is similar with natural bone tissue in biochemical components, biophysical characteristics such as pore size, porosity, and mechanics. These physical and chemical properties can not only provide a mechanically stable microenvironment but also regulate the fate of cells by affecting cell adhesion, migration, proliferation, and differentiation .…”
Section: Introductionmentioning
confidence: 99%
“…6,7 The decellularized bone matrix (DCB) constructed by removing the cellular and immunogenic components in the ECM of bone in vitro by physical, chemical, and enzymatic methods retains the structural characteristics and represents the native bonespecific microenvironment of ECM. 8,9 The DCB is similar with natural bone tissue in biochemical components, biophysical characteristics such as pore size, porosity, and mechanics. These physical and chemical properties can not only provide a mechanically stable microenvironment but also regulate the fate of cells by affecting cell adhesion, migration, proliferation, and differentiation.…”
Section: Introductionmentioning
confidence: 99%